Todd C. Davis, CHIEF EXECUTIVE OFFICER at LIGAND PHARMACEUTICALS INC (LGND), bought 4,000 shares at $59.38 ($238K) on 2023-09-22, disclosed to the SEC on 2023-09-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| LGND | BUY | 2024-08-09 | $243K | — | Filing → |
| LGND | SELL | 2021-02-12 | $2.2M | — | Filing → |
| BDSI | SELL | 2020-08-20 | $250K | — | Filing → |